3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
5
Phase 4
1
Phase 3
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Tobacco Use Cessation
1
Smoking Cessation
1
Sexuality
1
Pleural Effusion, Malignant
1
Neuroendocrine Tumors
1
Gastrointestinal Neoplasms
1
Acute Pain
1
Interventions
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
6
human papillomavirus vaccine, L1 type 16, 18
4
Vaccines
3
fluciclovine F-18
2
pegylated granulocyte colony-stimulating factor
1
halofantrine
1
ferrous fumarate
1
epoetin beta
1
apatinib
1
Tobacco Use Cessation Devices
1
TachoSil
1
Surveys and Questionnaires
1
Radiotherapy
1
Quality of Life
1
Psychiatric Rehabilitation
1
Polymerase Chain Reaction
1
Patient Navigation
1
Papillomavirus Vaccines
1
Mindfulness
1
Indocyanine Green
1
Human Papillomavirus Recombinant Vaccine nonavalent
1
Hepatitis B Vaccines
1
Gonadal Steroid Hormones
1
Gene Expression Profiling
1
Engerix-B
1
Early Intervention, Educational
1
Counseling
1
Cognitive Behavioral Therapy
1
Cisplatin
1
Bupropion
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Uterine Cervical Neoplasms
×
Surveys and Questionnaires
×
Clear all
NCT02837926
2019-04-10
CoheaHr-WP4
CHU de Reims
Phase 4
Completed
63 enrolled